118 related articles for article (PubMed ID: 7595400)
41. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
Yoon GS; Yu E
J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
[TBL] [Abstract][Full Text] [Related]
42. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors.
Fagioli M; Grignani F; Ferrucci PF; Alcalay M; Mencarelli A; Nicoletti I; Grignani F; Pelicci PG
Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308
[TBL] [Abstract][Full Text] [Related]
43. The Human CMV IE1 Protein: An Offender of PML Nuclear Bodies.
Scherer M; Schilling EM; Stamminger T
Adv Anat Embryol Cell Biol; 2017; 223():77-94. PubMed ID: 28528440
[TBL] [Abstract][Full Text] [Related]
44. Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures.
Everett R; O'Hare P; O'Rourke D; Barlow P; Orr A
J Virol; 1995 Nov; 69(11):7339-44. PubMed ID: 7474166
[TBL] [Abstract][Full Text] [Related]
45. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.
Borden KL; Campbelldwyer EJ; Carlile GW; Djavani M; Salvato MS
J Virol; 1998 May; 72(5):3819-26. PubMed ID: 9557665
[TBL] [Abstract][Full Text] [Related]
46. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
Borden KL; Campbell Dwyer EJ; Salvato MS
J Virol; 1998 Jan; 72(1):758-66. PubMed ID: 9420283
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies.
Salsman J; Zimmerman N; Chen T; Domagala M; Frappier L
PLoS Pathog; 2008 Jul; 4(7):e1000100. PubMed ID: 18617993
[TBL] [Abstract][Full Text] [Related]
48. PML bodies associate specifically with the MHC gene cluster in interphase nuclei.
Shiels C; Islam SA; Vatcheva R; Sasieni P; Sternberg MJ; Freemont PS; Sheer D
J Cell Sci; 2001 Oct; 114(Pt 20):3705-16. PubMed ID: 11707522
[TBL] [Abstract][Full Text] [Related]
49. Intrinsic cellular defense mechanisms targeting human cytomegalovirus.
Tavalai N; Stamminger T
Virus Res; 2011 May; 157(2):128-33. PubMed ID: 20934469
[TBL] [Abstract][Full Text] [Related]
50. Viral and cellular factors that target the promyelocytic leukemia oncogenic domains strongly activate a glucocorticoid-responsive promoter.
Wienzek S; Dobbelstein M
J Virol; 2001 Jun; 75(11):5391-7. PubMed ID: 11333923
[TBL] [Abstract][Full Text] [Related]
51. Cell type- and differentiation stage-dependent expression of PML domains in rat, detected by monoclonal antibody HIS55.
Lam YW; Ammerlaan W; O WS; Kroese F; Opstelten D
Exp Cell Res; 1995 Dec; 221(2):344-56. PubMed ID: 7493633
[TBL] [Abstract][Full Text] [Related]
52. Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells.
Kamei H
Exp Cell Res; 1997 Nov; 237(1):207-16. PubMed ID: 9417884
[TBL] [Abstract][Full Text] [Related]
53. SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract][Full Text] [Related]
54. Ca2+ responses in cytomegalovirus-infected fibroblasts of human origin.
Nokta M; Eaton D; Steinsland OS; Albrecht T
Virology; 1987 Apr; 157(2):259-67. PubMed ID: 3029971
[TBL] [Abstract][Full Text] [Related]
55. An endogenous accelerator for viral gene expression confers a fitness advantage.
Teng MW; Bolovan-Fritts C; Dar RD; Womack A; Simpson ML; Shenk T; Weinberger LS
Cell; 2012 Dec; 151(7):1569-80. PubMed ID: 23260143
[TBL] [Abstract][Full Text] [Related]
56. PML vaccines.
Pepper D
Vet Rec; 1987 Sep; 121(12):288. PubMed ID: 3672847
[No Abstract] [Full Text] [Related]
57. ISG20: an enigmatic antiviral RNase targeting multiple viruses.
Deymier S; Louvat C; Fiorini F; Cimarelli A
FEBS Open Bio; 2022 Jun; 12(6):1096-1111. PubMed ID: 35174977
[TBL] [Abstract][Full Text] [Related]
58. Expanding the Known Functional Repertoire of the Human Cytomegalovirus pp71 Protein.
Kalejta RF; Albright ER
Front Cell Infect Microbiol; 2020; 10():95. PubMed ID: 32226778
[TBL] [Abstract][Full Text] [Related]
59. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
[TBL] [Abstract][Full Text] [Related]
60. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.
Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
